Sign In
Buy WXIBF
$4.40
+0.220 (+5.26%)
At Close: Jun 03, 2026
WuXi Biologics (Cayman) Earnings Calls
Dec 31, 2025
| Release date | Mar 24, 2026 |
| EPS estimate | $0.0901 |
| EPS actual | $0.0901 |
| Revenue estimate | 1.692B |
| Revenue actual | 1.692B |
| Revenue Surprise | 0.0018% |
Jun 30, 2025
$0.0779 (24.09%)
| Release date | Aug 19, 2025 |
| EPS estimate | $0.0628 |
| EPS actual | $0.0779 |
| EPS Surprise | 24.09% |
| Revenue estimate | 1.363B |
| Revenue actual | 1.388B |
| Revenue Surprise | 1.83% |
Mar 30, 2025
| Release date | Jun 18, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
$0.0602 (-0.149%)
| Release date | Mar 25, 2025 |
| EPS estimate | $0.0603 |
| EPS actual | $0.0602 |
| EPS Surprise | -0.149% |
| Revenue estimate | 1.324B |
| Revenue actual | 1.383B |
| Revenue Surprise | 4.48% |
Last 4 Quarters for WuXi Biologics (Cayman)
Below you can see how WXIBF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2024
Missed
| Release date | Mar 25, 2025 |
| Price on release | $3.70 |
| EPS estimate | $0.0603 |
| EPS actual | $0.0602 |
| EPS surprise | -0.149% |
| Date | Price |
|---|---|
| Mar 19, 2025 | $3.70 |
| Mar 20, 2025 | $3.70 |
| Mar 21, 2025 | $3.70 |
| Mar 24, 2025 | $3.70 |
| Mar 25, 2025 | $3.70 |
| Mar 26, 2025 | $3.70 |
| Mar 27, 2025 | $3.70 |
| Mar 28, 2025 | $3.70 |
| Mar 31, 2025 | $3.70 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Mar 30, 2025
| Release date | Jun 18, 2025 |
| Price on release | $3.25 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 11, 2025 | $2.96 |
| Jun 12, 2025 | $3.21 |
| Jun 13, 2025 | $3.20 |
| Jun 16, 2025 | $3.21 |
| Jun 17, 2025 | $3.25 |
| Jun 19, 2025 | $3.25 |
| Jun 20, 2025 | $3.25 |
| Jun 23, 2025 | $3.25 |
| Jun 24, 2025 | $3.25 |
| 4 days before | 9.80% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 9.80% |
Jun 30, 2025
Beat
| Release date | Aug 19, 2025 |
| Price on release | $3.85 |
| EPS estimate | $0.0628 |
| EPS actual | $0.0779 |
| EPS surprise | 24.09% |
| Date | Price |
|---|---|
| Aug 13, 2025 | $3.85 |
| Aug 14, 2025 | $3.85 |
| Aug 15, 2025 | $4.00 |
| Aug 18, 2025 | $4.00 |
| Aug 19, 2025 | $3.85 |
| Aug 20, 2025 | $3.85 |
| Aug 21, 2025 | $4.20 |
| Aug 22, 2025 | $4.20 |
| Aug 25, 2025 | $4.20 |
| 4 days before | 0% |
| 4 days after | 9.09% |
| On release day | 0% |
| Change in period | 9.09% |
Dec 31, 2025
| Release date | Mar 24, 2026 |
| Price on release | $4.60 |
| EPS estimate | $0.0901 |
| EPS actual | $0.0901 |
| Date | Price |
|---|---|
| Mar 18, 2026 | $4.60 |
| Mar 19, 2026 | $4.60 |
| Mar 20, 2026 | $4.60 |
| Mar 23, 2026 | $4.60 |
| Mar 24, 2026 | $4.60 |
| Mar 25, 2026 | $4.60 |
| Mar 26, 2026 | $4.60 |
| Mar 27, 2026 | $4.60 |
| Mar 30, 2026 | $4.60 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
WuXi Biologics (Cayman) Earnings History
Earnings Calendar
FAQ
When is the earnings report for WXIBF?
WuXi Biologics (Cayman) Inc. (WXIBF) has scheduled its earnings report for Aug 26, 2026 after the markets close.
What is the WXIBF price-to-earnings (P/E) ratio?
WXIBF P/E ratio as of Jun 03, 2026 (TTM) is 24.24.
What is the WXIBF EPS forecast?
The forecasted EPS (Earnings Per Share) for WuXi Biologics (Cayman) Inc. (WXIBF) for the first fiscal quarter 2026 is $0.0872.
What are WuXi Biologics (Cayman) Inc.'s retained earnings?
On its balance sheet, WuXi Biologics (Cayman) Inc. reported retained earnings of $1.69 billion for the latest quarter ending Dec 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
